Replies to post #34886 on Intellipharmaceutics International Inc. (IPCI)

[mopar44o]

If you get the license back but have no one to sell it what value does it have? There is still the potential that sales pick up. No point getting it back if there is no better options.

[doogdilinger]

No clue what any of their generics plans are anymore blue. I'm just hoping they get moving on POC human trials on PODRAS and secure a large R&D partner on their Regabatin NDA candidate.

Those 2 things alone are far and away more important than anything to do with their failed generics pipeline to date.

They just had atrocious timing with their MNK deal so we can add that to the list of disappointments and unforeseen bad luck that befell them over the past 4 years right.

Hopefully they do have some sorta plans for generics in China as they've said...as I'll consider any positive progress of any kind whatsoever from their generics pipeline a bonus now through end of year glty

[swe77]

They are looking into that matter. It really depends on how good their lawyers were who worked on the contract.

The non-performance clause is a very subjective matter.

I highly doubt they are going to partner Ranexa with MNK whenever it gets approved.